Stockholm, Sweden – iZafe Group AB (publ.) (NASDAQ First North: IZAFE B) – a leading Life Science company specializing in healthcare services digitalization announces the opportunity for shareholders, media, and other stakeholders to ask company-related questions in connection with its Third Quarter 2020 report. The report will be available to the public on on November 9, 2020 at 08.30 (8:30 a.m.) CET. Questions will be answered by Chief Executive Officer Anders Segerström in a video presentation that will be published on November 18, 2020 on iZafe's website under the heading Investor Relations.
Please send your questions to ir@izafe.se before 17:00 (5 p.m.) CET on November 10, 2020. You can also use an online form to send your questions. This form is available on iZafe's website, Investor Relations page.
Contacts
Thomas Ahlerup, IR contact
E-mail: thomas.ahlerup@izafe.se
Phone number: +46 76-896 63 00
iZafe Group AB (publ)
Grev Turegatan 11A
114 46 Stockholm
E-mail: ir@izafe.se
investor.izafe.se
About Us
iZafe Group is a Swedish med-tech company that develops and markets medical and digital security solutions to create safer drug handling at home. Our digital medicine dispenser Dosell reduces the risk of incorrect medication, increases security for family and relatives and relieves public care personnel. Our products form a holistic concept that facilitates patient medication and gives those who are treated at home better conditions for a happy and safe life.
The company is listed on the NASDAQ First North Premier Growth Market. FNCA Sweden AB is the company's Certified Adviser. Phone: +46 (0) 8 528 00 399. E-mail: info@fnca.se. Further information is available at investor.izafe.se.